Can Diabetics Take Fish Oil Safely?

Fish oil is generally safe for people with diabetes, and multiple meta-analyses spanning decades confirm it does not worsen blood sugar control. The main concern that kept clinicians cautious for years, that supplemental omega-3 fatty acids might raise fasting glucose or destabilize glycemic management, has been thoroughly studied and largely put to rest. That said, fish oil is not a neutral substance: it lowers triglycerides, can nudge LDL cholesterol upward, and interacts with the metabolic landscape of diabetes in ways that deserve a closer look before you start or change a supplement routine.

How Fish Oil Affects Blood Sugar Control

The safety question people with diabetes care about most is straightforward: will fish oil raise my blood sugar? The answer, across several large analyses, is no. A meta-analysis published in Diabetes Care found no significant changes in HbA1c in people with diabetes who took fish oil.¹ A separate systematic review in the same journal reached the same conclusion: no statistically significant effect on fasting glucose or HbA1c.²

More recent data confirms this pattern. A 2020 meta-analysis of randomized controlled trials in people with type 2 diabetes found no meaningful difference in fasting plasma glucose, fasting insulin, HbA1c, or insulin resistance between fish oil and placebo groups.³ A separate meta-analysis looking specifically at insulin sensitivity found that fish oil had no effect overall, though a subgroup of people who already had symptoms of metabolic disorders did show improvement.⁴

A small pilot study in overweight and obese people with type 2 diabetes offered a hint at why that subgroup effect might exist. After fish oil supplementation, participants showed reduced levels of several inflammatory markers and improved insulin resistance scores, without changes in weight or body composition.⁵ The anti-inflammatory properties of omega-3 fatty acids may help the body use insulin more effectively in people whose chronic low-grade inflammation is part of the problem. But at the population level, across many trials, the net effect on blood sugar remains essentially zero.

Triglycerides, Cholesterol, and the LDL Trade-Off

Where fish oil does make a clear mark is on triglycerides. A Cochrane review of trials in people with type 2 diabetes found that fish oil lowered triglycerides significantly while also raising LDL cholesterol, with both effects being most pronounced at higher doses and in people whose triglycerides were already elevated.⁶ That LDL increase is real and worth taking seriously, especially in a population already at elevated cardiovascular risk. Clinical nutrition guidelines in Diabetes Care have long reflected this tension, recommending fish oil for people with persistently high triglycerides while noting that LDL cholesterol should be monitored.⁷

The LDL story is not entirely straightforward, though. One trial that compared fish oil to corn oil in people with type 2 diabetes found no significant effects on total LDL cholesterol, HDL cholesterol, or the concentration of the small, dense LDL particles that are considered the most harmful.⁸ The rise in LDL that shows up in pooled analyses may reflect increases in the larger, less dangerous LDL particles rather than the atherogenic small dense ones. Still, until more studies sort this out, keeping an eye on your lipid panel after starting fish oil is sensible.

Heart Protection for People With Diabetes

The cardiovascular payoff is where the evidence gets interesting. A meta-analysis of randomized controlled trials in patients with diabetes found that omega-3 supplementation reduced overall cardiovascular disease risk by about 7%. But the benefit was not evenly distributed across different formulations. EPA alone showed a much stronger effect, cutting cardiovascular risk by roughly 19%, while the combination of EPA plus DHA did not reach statistical significance.⁹ This finding echoes a broader trend in cardiovascular research: high-dose purified EPA appears to be the more potent player for heart protection, at least in clinical trials. Most over-the-counter fish oil supplements contain a mix of EPA and DHA, which matters when you are thinking about what product to use.

For people with diabetes, who face roughly double the cardiovascular risk of the general population, even a modest reduction is meaningful. The evidence is strong enough that the authors of that meta-analysis described omega-3 supplementation as an effective strategy for cardiovascular disease prevention in this group.

Effects on Diabetic Eye, Nerve, and Kidney Disease

Beyond blood sugar and heart risk, fish oil may help protect against some of the complications that make diabetes so damaging over time. The evidence varies by complication, but there are promising signals across all three major microvascular targets.

Retinopathy

Diabetic retinopathy is one of the leading causes of vision loss worldwide. A large prospective study from the PREDIMED trial found that people with type 2 diabetes who consumed at least 500 mg per day of EPA and DHA had a 46% lower risk of developing sight-threatening retinopathy compared with those who consumed less.¹⁰ A systematic review and meta-analysis including over 139,000 participants confirmed this association, finding a 48% reduction in sight-threatening retinopathy risk at the 500 mg/day threshold, with a stronger protective effect in type 2 diabetes than in type 1.¹¹

Research in people with type 1 diabetes adds another dimension. Higher blood levels of marine omega-3 fatty acids were associated with lower retinopathy grades and better-preserved blood flow in the retina.¹² These are observational findings, not proof that fish oil capsules prevent eye disease, but the consistency of the data across study designs and populations is notable.

Neuropathy

Diabetic neuropathy, the nerve damage that causes numbness, tingling, and pain in the extremities, has fewer human trials but encouraging preclinical work. Animal studies using diabetic rodent models have shown that fish oil can slow the progression of neuropathy and even partially reverse it, as measured by improvements in nerve conduction speed.¹³ Specific compounds derived from the omega-3 fatty acids in fish oil, called resolvins, appear to be neuroprotective and can stimulate nerve cell growth in laboratory settings.¹⁴ Human clinical trials are needed before fish oil can be recommended specifically for neuropathy, but the mechanistic picture is plausible.

Nephropathy

Kidney damage in diabetes often shows up as protein leaking into the urine. A meta-analysis of randomized controlled trials found that omega-3 fatty acids reduced proteinuria in people with type 2 diabetes, with the effect becoming significant only in studies lasting 24 weeks or longer.¹⁵ A separate trial, the GO-FISH study, found that omega-3 supplementation did not significantly lower albumin excretion overall but did reduce a biomarker of kidney tubule injury called NGAL by about 16%. Among participants who were also taking drugs that protect the kidneys, reductions were seen across nearly all markers of kidney damage.¹⁶ The kidney evidence is more preliminary than the eye data, but it points in a consistent direction.

Prescription Omega-3s vs Store-Bought Supplements

Not all fish oil is the same, and this matters more than most people realize. Prescription omega-3 products go through full FDA approval, which means they must demonstrate safety and efficacy and are subject to ongoing quality monitoring. Over-the-counter fish oil supplements are regulated as dietary supplements, a much lower bar. Reviews have documented variable EPA and DHA content that sometimes does not match what the label claims, along with contaminants, unwanted cholesterol, saturated fats, and oxidized fatty acids.¹⁷

Prescription products are highly purified and deliver standardized doses, typically at much higher concentrations of EPA and DHA than what you get from a supplement-aisle bottle. Clinicians have emphasized that the two should not be treated as interchangeable: supplements may be fine for general health promotion, but they are not medications and should not be substituted when a doctor prescribes a pharmaceutical-grade omega-3 for a specific condition like severe hypertriglyceridemia.¹⁸ If your doctor recommends omega-3s specifically to manage triglycerides or cardiovascular risk, ask whether they mean a prescription product or are comfortable with a supplement.¹⁹

Marine and Plant-Based Omega-3s Work Differently

Fish oil provides EPA and DHA, the long-chain omega-3 fatty acids that the body uses most readily. Plant sources like flaxseed, chia seeds, and perilla oil deliver alpha-linolenic acid (ALA), a shorter-chain omega-3 that the body must convert into EPA and DHA before using it. That conversion is inefficient in humans, and it turns out the metabolic effects are genuinely different in people with diabetes.

A trial comparing fish oil to perilla oil (a plant-based omega-3 source rich in ALA) in people with diabetes found that the two had distinct effects. Perilla oil lowered fasting blood glucose, while fish oil lowered triglycerides. Neither did what the other did well.²⁰ A companion study looking at how these oils changed the fatty acid composition of red blood cells confirmed that marine-based and plant-based omega-3s follow different metabolic pathways and regulate blood sugar and lipids differently.²¹

This means you cannot assume that swapping fish oil for flaxseed oil will give you the same benefits for triglycerides or cardiovascular risk. If lowering triglycerides is the goal, marine-derived omega-3s are the ones supported by the trial evidence. If you prefer plant sources for dietary or ethical reasons, the metabolic trade-offs are worth discussing with your care team.

Potential Risks and Interactions

Fish oil is well-tolerated by most people, but it is not risk-free. The most commonly discussed side effects at standard doses are gastrointestinal: fishy burps, nausea, and loose stools. At higher doses, more clinically meaningful concerns emerge.

One risk that has received growing attention is atrial fibrillation. A meta-analysis found a link between omega-3 supplementation and increased risk of this heart rhythm disorder.²² The risk appears to be dose-dependent, meaning it is more of a concern with the high-dose prescription products used to treat very high triglycerides than with a standard supplement. If you have a history of atrial fibrillation or are at elevated risk for it, this is something to raise with your doctor before starting any omega-3 regimen.

Many people with diabetes take aspirin for cardiovascular protection, so interactions between fish oil and blood-thinning medications are a reasonable worry. A study in adults with diabetes found something surprising: rather than amplifying bleeding risk, fish oil actually appeared to help aspirin work better in people who were initially resistant to aspirin’s antiplatelet effects. After a week of combined aspirin and fish oil use, the majority of previously aspirin-insensitive participants became aspirin-sensitive.²³ This is preliminary and does not rule out increased bleeding risk in all situations, but it suggests the interaction may be more nuanced than a simple additive effect.

For people taking metformin, the most common first-line medication for type 2 diabetes, a pilot trial in women with polycystic ovary syndrome found that combining fish oil with metformin lowered fasting triglycerides by more than 40%, substantially more than either treatment alone.²⁴ While that trial was not conducted specifically in people with diabetes, it suggests the combination may be complementary rather than problematic.

Clinical nutrition guidelines have recommended two to three servings of fish per week as a dietary baseline for people with diabetes, with supplemental fish oil as an option for persistently high triglycerides. The guidelines also note that patients with extremely high triglycerides (above 1,000 mg/dL) need a different approach entirely, including restriction of all dietary fats and lipid-lowering medication, because they are at risk for pancreatitis.²⁵

Fish Oil and Body Composition in Type 2 Diabetes

Visceral fat, the deep abdominal fat wrapped around organs, is both a consequence and a driver of insulin resistance in type 2 diabetes. A randomized, double-blind trial gave people with type 2 diabetes either DHA-rich fish oil or a placebo and tracked their body composition. The fish oil group saw significant reductions in waist circumference, total body fat percentage, visceral fat, and trunk fat mass, with no change in overall body weight or lean muscle mass.²⁶ The scale did not budge, in other words, but the distribution of fat shifted in a favorable direction. This is a single trial and should not be over-interpreted, but for people with type 2 diabetes who are trying to reduce visceral adiposity, it is an intriguing finding that warrants larger follow-up studies.

A large population-based prospective study adds broader context. Among over 400,000 participants tracked for a median of ten years, those who regularly consumed oily fish had a roughly 22% lower risk of developing type 2 diabetes in the first place, and regular fish oil supplement users had a 9% lower risk compared with nonusers. People who consistently used fish oil throughout the study period had an 18% lower risk.²⁷ This does not prove that fish oil prevents diabetes, since supplement users tend to differ from nonusers in other health behaviors, but it does suggest that habitual omega-3 intake fits comfortably within a metabolically healthy lifestyle.